{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:30:05Z","timestamp":1793946605176,"version":"4.8.0"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2025-I2M-XHXX-011"],"award-info":[{"award-number":["2025-I2M-XHXX-011"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011176","name":"Peking Union Medical College","doi-asserted-by":"publisher","award":["UHB12051"],"award-info":[{"award-number":["UHB12051"]}],"id":[{"id":"10.13039\/501100011176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574986"],"award-info":[{"award-number":["82574986"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274336"],"award-info":[{"award-number":["82274336"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.metabol.2026.156601","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:56:49Z","timestamp":1774461409000},"page":"156601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Proteomics and metabolomics biomarkers for predicting the onset and progression of diabetic complications: A systematic review and bioinformatics integration"],"prefix":"10.1016","volume":"180","author":[{"given":"Wei","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adila","family":"Maimaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2026.156601_bb0005","series-title":"International Diabetes Federation [Internet]. IDF Diabetes Atlas","year":"2025"},{"issue":"105","key":"10.1016\/j.metabol.2026.156601_bb0010","first-page":"S117","article-title":"clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"2024","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2026.156601_bb0015","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/j.ekir.2021.09.007","article-title":"Pathologic diabetic nephropathy in autopsied diabetic cases with normoalbuminuria from a Japanese community-based study","volume":"6","author":"Sasaki","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.metabol.2026.156601_bb0020","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.2337\/dc12-2572","article-title":"Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function","volume":"36","author":"Ekinci","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2026.156601_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.70032","article-title":"Impact of muscle mass on the performance of creatinine-based eGFR equations and mortality risk assessment after kidney transplantation","volume":"16","author":"Gaillard","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.metabol.2026.156601_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156015","article-title":"Diagnostics and omics technologies for the detection and prediction of metabolic dysfunction-associated steatotic liver disease-related malignancies","volume":"161","author":"Lan","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156601_bb0035","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.ophtha.2024.07.004","article-title":"Plasma metabolomics identifies key metabolites and improves prediction of diabetic retinopathy: development and validation across multinational cohorts","volume":"131","author":"Yang","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.metabol.2026.156601_bb0040","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1053\/j.ajkd.2020.01.019","article-title":"Metabolomic markers of kidney function decline in patients with diabetes: evidence from the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"76","author":"Kwan","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.metabol.2026.156601_bb0045","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1038\/s41598-018-32085-y","article-title":"Metabolomic profile predicts development of microalbuminuria in individuals with type 1 diabetes","volume":"8","author":"Haukka","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2026.156601_bb0050","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1210\/clinem\/dgad452","article-title":"Metabolites as risk factors for diabetic retinopathy in patients with type 2 diabetes: a 12-year follow-up study","volume":"109","author":"Fernandes Silva","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2026.156601_bb0055","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.7326\/M22-0276","article-title":"QUAPAS: an adaptation of the QUADAS-2 tool to assess prognostic accuracy studies","volume":"175","author":"Lee","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2026.156601_bb0060","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.clinbiochem.2008.06.018","article-title":"QUADOMICS: an adaptation of the Quality Assessment of Diagnostic Accuracy Assessment (QUADAS) for the evaluation of the methodological quality of studies on the diagnostic accuracy of \u2018-omics\u2019-based technologies","volume":"41","author":"Lumbreras","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1016\/j.metabol.2026.156601_bb0065","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2337\/dc24-1696","article-title":"Large-scale plasma proteomics improves prediction of peripheral artery disease in Individuals with type 2 diabetes: a prospective cohort study","volume":"48","author":"Yu","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2026.156601_bb0070","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1007\/s00125-024-06109-4","article-title":"Elevated ITGA1 levels in type 2 diabetes: implications for cardiac function impairment","volume":"67","author":"Su","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2026.156601_bb0075","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41467-025-56695-z","article-title":"Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities","volume":"16","author":"Loesch","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2026.156601_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2022.100196","article-title":"Pulmonary surfactant protein B carried by HDL predicts incident CVD in patients with type 1 diabetes","volume":"63","author":"Shao","year":"2022","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2026.156601_bb0085","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jdiacomp.2018.09.012","article-title":"Application of urinary proteomics as possible risk predictor of renal and cardiovascular complications in patients with type 2-diabetes and microalbuminuria","volume":"32","author":"Oellgaard","year":"2018","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.metabol.2026.156601_bb0090","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.3390\/ijms25105365","article-title":"Apolipoprotein-CIII O-glycosylation is associated with micro- and macrovascular complications of type 2 diabetes","volume":"25","author":"Naber","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2026.156601_bb0095","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002345","article-title":"Plasma protein N-glycosylation is associated with cardiovascular disease, nephropathy, and retinopathy in type 2 diabetes","volume":"9","author":"Memarian","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.metabol.2026.156601_bb0100","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s00392-020-01729-3","article-title":"Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial","volume":"110","author":"Ferreira","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.metabol.2026.156601_bb0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/03009734.2019.1696430","article-title":"Growth differentiation factor 15 (GDF-15) is a potential biomarker of both diabetic kidney disease and future cardiovascular events in cohorts of individuals with type 2 diabetes: a proteomics approach","volume":"125","author":"Carlsson","year":"2020","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.metabol.2026.156601_bb0110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/s12933-024-02512-8","article-title":"Urinary metabolomics provide insights into coronary artery disease in individuals with type 1 diabetes","volume":"23","author":"Antikainen","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2026.156601_bb0115","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12933-022-01494-9","article-title":"Prognostic significance of metabolomic biomarkers in patients with diabetes mellitus and coronary artery disease","volume":"21","author":"Karagiannidis","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2026.156601_bb0120","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00125-024-06108-5","article-title":"Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank","volume":"67","author":"Jin","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2026.156601_bb0125","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.116.023233","article-title":"Plasma lipidomic profiles improve on traditional risk factors for the prediction of cardiovascular events in type 2 diabetes mellitus","volume":"134","author":"Alshehry","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2026.156601_bb0130","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s00125-020-05201-9","article-title":"Sphingomyelin and progression of renal and coronary heart disease in individuals with type 1 diabetes","volume":"63","author":"Pongrac Barlovic","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2026.156601_bb0135","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00125-018-4619-x","article-title":"Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial","volume":"61","author":"Welsh","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2026.156601_bb0140","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12933-018-0697-9","article-title":"Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria","volume":"17","author":"Currie","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2026.156601_bb0145","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1210\/clinem\/dgae266","article-title":"Plasma proteomics of diabetic kidney disease among Asians with younger-onset type 2 diabetes","volume":"110","author":"Gurung","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2026.156601_bb0150","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.178373","article-title":"Circulating proteins linked to apoptosis processes and fast development of end-stage kidney disease in diabetes","volume":"9","author":"Ihara","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.metabol.2026.156601_bb0155","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.kint.2020.07.007","article-title":"A profile of multiple circulating tumor necrosis factor receptors associated with early progressive kidney decline in Type 1 Diabetes is similar to profiles in autoimmune disorders","volume":"99","author":"Ihara","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2026.156601_bb0160","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj2109","article-title":"Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes","volume":"14","author":"Kobayashi","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.metabol.2026.156601_bb0165","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.kint.2022.04.022","article-title":"Results of untargeted analysis using the SOMAscan proteomics platform indicates novel associations of circulating proteins with risk of progression to kidney failure in diabetes","volume":"102","author":"Kobayashi","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2026.156601_bb0170","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/jcm9030639","article-title":"Urine E-cadherin: a marker for early detection of kidney injury in diabetic patients","volume":"9","author":"Koziolek","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.metabol.2026.156601_bb0175","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3390\/jcm7120483","article-title":"Urinary proteomics for the early diagnosis of diabetic nephropathy in Taiwanese patients","volume":"7","author":"Liao","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.metabol.2026.156601_bb0180","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.2337\/dc21-2204","article-title":"Urinary proteomics identifies cathepsin D as a biomarker of rapid eGFR decline in type 1 diabetes","volume":"45","author":"Limonte","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2026.156601_bb0185","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1093\/ndt\/gfw292","article-title":"Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study","volume":"32","author":"Lindhardt","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.metabol.2026.156601_bb0190","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.2337\/db22-0169","article-title":"Multi-scalar data integration links glomerular angiopoietin-Tie signaling pathway activation with progression of diabetic kidney disease","volume":"71","author":"Liu","year":"2022","journal-title":"Diabetes Diabetes"},{"key":"10.1016\/j.metabol.2026.156601_bb0195","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd2699","article-title":"Circulating proteins protect against renal decline and progression to end-stage renal disease in patients with diabetes","volume":"13","author":"Md Dom","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.metabol.2026.156601_bb0200","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41591-019-0415-5","article-title":"A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes","volume":"25","author":"Niewczas","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2026.156601_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2019.07.003","article-title":"Validation of a protein biomarker test for predicting renal decline in type 2 diabetes: the Fremantle Diabetes Study Phase II","volume":"33","author":"Peters","year":"2019","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.metabol.2026.156601_bb0210","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3390\/diagnostics15060662","article-title":"PromarkerD versus standard of care biochemical measures for assessing future renal function decline in type 2 diabetes","volume":"15","author":"Peters","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.metabol.2026.156601_bb0215","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.2215\/CJN.0000000000000559","article-title":"Proteomic analysis uncovers multiprotein signatures associated with early diabetic kidney disease in youth with type 2 diabetes mellitus","volume":"19","author":"Pyle","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2026.156601_bb0220","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-8587(20)30026-7","article-title":"Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial","volume":"8","author":"Tofte","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2026.156601_bb0225","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2337\/dc16-1529","article-title":"Urine proteome specific for eye damage can predict kidney damage in patients with type 2 diabetes: a case-control and a 5.3-year prospective cohort study","volume":"40","author":"Yang","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2026.156601_bb0230","article-title":"Urine complement proteins are associated with kidney disease progression of type 2 diabetes in Korean and American cohorts","author":"Yun","year":"2024","journal-title":"medRxiv [Preprint]"},{"key":"10.1016\/j.metabol.2026.156601_bb0235","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ekir.2025.04.061","article-title":"Complement proteins identify rapidly progressive diabetic kidney disease","volume":"10","author":"Yun","year":"2025","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.metabol.2026.156601_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2025.101265","article-title":"Prioritization of potential drug targets for diabetic kidney disease using integrative omics data mining and causal inference","volume":"15","author":"Zhang","year":"2025","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.metabol.2026.156601_bb0245","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1038\/s41598-021-83856-z","article-title":"Solidified glomerulosclerosis, identified using single glomerular proteomics, predicts end-stage renal disease in Chinese patients with type 2 diabetes","volume":"11","author":"Zhao","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2026.156601_bb0250","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00125-024-06324-z","article-title":"Metabolomics profiling in multi-ancestral individuals with type 2 diabetes in Singapore identified metabolites associated with renal function decline","volume":"68","author":"Chen","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2026.156601_bb0255","doi-asserted-by":"crossref","first-page":"16287","DOI":"10.1038\/s41598-022-20638-1","article-title":"Potential progression biomarkers of diabetic kidney disease determined using comprehensive machine learning analysis of non-targeted metabolomics","volume":"12","author":"Hirakawa","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2026.156601_bb0260","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.18632\/aging.205542","article-title":"Insights into serum metabolic biomarkers for early detection of incident diabetic kidney disease in Chinese patients with type 2 diabetes by random forest","volume":"16","author":"Jiang","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.metabol.2026.156601_bb0265","doi-asserted-by":"crossref","first-page":"445","DOI":"10.23876\/j.krcp.22.152","article-title":"Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance","volume":"42","author":"Kwon","year":"2023","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.metabol.2026.156601_bb0270","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jacl.2019.03.005","article-title":"Glycosylated sphingolipids and progression to kidney dysfunction in type 1 diabetes","volume":"13","author":"Lopes-Virella","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.metabol.2026.156601_bb0275","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s00125-021-05584-3","article-title":"Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes","volume":"65","author":"Mutter","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2026.156601_bb0280","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/dme.12447","article-title":"Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus","volume":"31","author":"Pena","year":"2014","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2026.156601_bb0285","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2023-003973","article-title":"Circulating metabolomic markers in association with overall burden of microvascular complications in type 1 diabetes","volume":"12","author":"Rotbain Curovic","year":"2024","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.metabol.2026.156601_bb0290","doi-asserted-by":"crossref","DOI":"10.1172\/JCI170341","article-title":"Endogenous adenine mediates kidney injury in diabetic models and predicts diabetic kidney disease in patients","volume":"133","author":"Sharma","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2026.156601_bb0295","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11306-018-1337-9","article-title":"1,5-Anhydroglucitol predicts CKD progression in macroalbuminuric diabetic kidney disease: results from non-targeted metabolomics","volume":"14","author":"Tavares","year":"2018","journal-title":"Metabolomics"},{"key":"10.1016\/j.metabol.2026.156601_bb0300","doi-asserted-by":"crossref","first-page":"16398","DOI":"10.1038\/s41598-019-52916-w","article-title":"Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes","volume":"9","author":"Tofte","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2026.156601_bb0305","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3389\/fendo.2019.00818","article-title":"Metabolomic assessment reveals alteration in polyols and branched chain amino acids associated with present and future renal impairment in a discovery cohort of 637 persons with type 1 diabetes","volume":"10","author":"Tofte","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.metabol.2026.156601_bb0310","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11306-011-0291-6","article-title":"Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study)","volume":"8","author":"van der Kloet","year":"2012","journal-title":"Metabolomics"},{"key":"10.1016\/j.metabol.2026.156601_bb0315","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000521940","article-title":"High-throughput metabolomics and diabetic kidney disease progression: evidence from the Chronic Renal Insufficiency (CRIC) Study","volume":"53","author":"Zhang","year":"2022","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.metabol.2026.156601_bb0320","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1007\/s00125-019-4915-0","article-title":"Biomarker panels associated with progression of renal disease in type 1 diabetes","volume":"62","author":"Colombo","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2026.156601_bb0325","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.kint.2019.07.025","article-title":"Integrative analysis of prognostic biomarkers derived from multiomics panels helps discrimination of chronic kidney disease trajectories in people with type 2 diabetes","volume":"96","author":"Kammer","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2026.156601_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2024.105167","article-title":"A candidate panel of eight urinary proteins shows potential of early diagnosis and risk assessment for diabetic kidney disease in type 1 diabetes","volume":"300","author":"Altman","year":"2024","journal-title":"J Proteomics"},{"key":"10.1016\/j.metabol.2026.156601_bb0335","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12014-021-09338-6","article-title":"Urine proteomics identifies biomarkers for diabetic kidney disease at different stages","volume":"18","author":"Fan","year":"2021","journal-title":"Clin Proteomics"},{"key":"10.1016\/j.metabol.2026.156601_bb0340","doi-asserted-by":"crossref","first-page":"27","DOI":"10.20452\/pamw.2640","article-title":"Changes in urine proteome accompanying diabetic nephropathy progression","volume":"125","author":"Lewandowicz","year":"2015","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.metabol.2026.156601_bb0345","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13098-019-0430-1","article-title":"Characterization of low molecular weight urinary proteins at varying time intervals in type 2 diabetes mellitus and diabetic nephropathy patients","volume":"11","author":"Patel","year":"2019","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.metabol.2026.156601_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.108834","article-title":"Investigating HMGB1 as a potential serum biomarker for early diabetic nephropathy monitoring by quantitative proteomics","volume":"27","author":"Peng","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.metabol.2026.156601_bb0355","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1021\/acs.jproteome.4c00267","article-title":"Application of proteomics and machine learning methods to study the pathogenesis of diabetic nephropathy and screen urinary biomarkers","volume":"23","author":"Yan","year":"2024","journal-title":"J Proteome Res"},{"key":"10.1016\/j.metabol.2026.156601_bb0360","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.7150\/thno.80435","article-title":"Integration of metabolomics and peptidomics reveals distinct molecular landscape of human diabetic kidney disease","volume":"13","author":"Jiang","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.metabol.2026.156601_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101367","article-title":"Serum integrative omics reveals the landscape of human diabetic kidney disease","volume":"54","author":"Liu","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.metabol.2026.156601_bb0370","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1541440","article-title":"Serum metabolic profiling of patients with diabetic kidney disease based on gas chromatography-mass spectrometry","volume":"12","author":"Bian","year":"2025","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.metabol.2026.156601_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112215","article-title":"Metabolic profile of urine of albuminuric and non-albuminuric nephropathic diabetic patients suggests TCA-cycle related biomarkers","volume":"225","author":"Braga","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.metabol.2026.156601_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2025.100354","article-title":"Lipidomics reveals potential biomarkers and pathophysiological insights in the progression of diabetic kidney disease","volume":"25","author":"Guo","year":"2025","journal-title":"Metab Open"},{"key":"10.1016\/j.metabol.2026.156601_bb0385","doi-asserted-by":"crossref","first-page":"12179","DOI":"10.1038\/s41598-025-91281-9","article-title":"Predicting diabetic kidney disease with serum metabolomics and gut microbiota","volume":"15","author":"Hu","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2026.156601_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116240","article-title":"Targeted and untargeted serum NMR metabolomics to reveal initial kidney disease in diabetes mellitus","volume":"247","author":"Lucio-Guti\u00e9rrez","year":"2024","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.metabol.2026.156601_bb0395","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.3390\/jcm13164703","article-title":"Biomarker profiling with targeted metabolomic analysis of plasma and urine samples in patients with type 2 diabetes mellitus and early diabetic kidney disease","volume":"13","author":"Mogos","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.metabol.2026.156601_bb0400","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.3390\/biomedicines11061527","article-title":"Metabolomic investigation of blood and urinary amino acids and derivatives in patients with type 2 diabetes mellitus and early diabetic kidney disease","volume":"11","author":"Mogos","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.metabol.2026.156601_bb0405","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.dsx.2020.10.017","article-title":"Identification of biomarkers for early diagnosis of diabetic nephropathy disease using direct flow through mass spectrometry","volume":"14","author":"Nilavan","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.metabol.2026.156601_bb0410","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1080\/0886022X.2022.2118067","article-title":"Extracellular vesicles metabolic changes reveals plasma signature in stage-dependent diabetic kidney disease","volume":"44","author":"Pan","year":"2022","journal-title":"Ren Fail"},{"key":"10.1016\/j.metabol.2026.156601_bb0415","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.2337\/dc24-S011","article-title":"11. Chronic kidney disease and risk management: standards of care in diabetes-2024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2026.156601_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.107853","article-title":"Assessment of biomarkers associated with rapid renal decline in the detection of retinopathy and its progression in type 2 diabetes: The Fremantle Diabetes Study Phase II","volume":"35","author":"Drinkwater","year":"2021","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.metabol.2026.156601_bb0425","doi-asserted-by":"crossref","first-page":"13456","DOI":"10.1038\/s41598-025-98327-y","article-title":"Identification of unique biomarkers for proliferative diabetic retinopathy with tractional retinal detachment by proteomics profiling of vitreous humor","volume":"15","author":"Liu","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2026.156601_bb0430","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/jamaophthalmol.2022.1175","article-title":"Multicenter evaluation of diagnostic circulating biomarkers to detect sight-threatening diabetic retinopathy","volume":"140","author":"Gurudas","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.metabol.2026.156601_bb0435","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1080\/02713683.2022.2068181","article-title":"Proteome changes associated with the VEGFR pathway and immune system in diabetic macular edema patients at different diabetic retinopathy stages","volume":"47","author":"Han","year":"2022","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.metabol.2026.156601_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2025.100953","article-title":"Proteomic analysis of aqueous humor identified clinically relevant molecular targets for neovascular complications in diabetic retinopathy","volume":"24","author":"Oh","year":"2025","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.metabol.2026.156601_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109724","article-title":"Proteomic analysis of aqueous humor reveals novel regulators of diabetic macular edema","volume":"239","author":"Zhang","year":"2024","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.metabol.2026.156601_bb0450","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1515\/cclm-2023-1128","article-title":"Proteomic analysis of diabetic retinopathy identifies potential plasma-protein biomarkers for diagnosis and prognosis","volume":"62","author":"Honor\u00e9","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.metabol.2026.156601_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.464700","article-title":"Separation of high-purity plasma extracellular vesicles for investigating proteomic signatures in diabetic retinopathy","volume":"1718","author":"Wang","year":"2024","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.metabol.2026.156601_bb0460","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/s12967-025-06452-z","article-title":"Stage-dependent proteomic alterations in aqueous humor of diabetic retinopathy patients based on data-independent acquisition and parallel reaction monitoring","volume":"23","author":"Jin","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.metabol.2026.156601_bb0465","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1167\/iovs.19-27321","article-title":"Arginine and carnitine metabolites are altered in diabetic retinopathy","volume":"60","author":"Sumarriva","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.metabol.2026.156601_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e16109","article-title":"Azelaic acid and guanosine in tears improve discrimination of proliferative from non-proliferative diabetic retinopathy in type-2 diabetes patients: A tear metabolomics study","volume":"9","author":"Wen","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.metabol.2026.156601_bb0475","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s40200-024-01462-y","article-title":"Dysregulation of amino acids balance as potential serum-metabolite biomarkers for diagnosis and prognosis of diabetic retinopathy: a metabolomics study","volume":"23","author":"Amiri-Dashatan","year":"2024","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.metabol.2026.156601_bb0480","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3390\/diagnostics14131364","article-title":"Hybrid explainable artificial intelligence models for targeted metabolomics analysis of diabetic retinopathy","volume":"14","author":"Yagin","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.metabol.2026.156601_bb0485","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.3390\/pharmaceutics14122751","article-title":"Integrated analysis of metabolomics and lipidomics in plasma of T2DM patients with diabetic retinopathy","volume":"14","author":"Ding","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.metabol.2026.156601_bb0490","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1364609","article-title":"Levels of asymmetric dimethylarginine in plasma and aqueous humor: a key risk factor for the severity of fibrovascular proliferation in proliferative diabetic retinopathy","volume":"15","author":"Guo","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.metabol.2026.156601_bb0495","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.clnesp.2024.03.013","article-title":"Metabolomic analysis of retinopathy stages and amputation in type 2 diabetes","volume":"61","author":"Diniz","year":"2024","journal-title":"Clinical Nutrition ESPEN"},{"key":"10.1016\/j.metabol.2026.156601_bb0500","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40942-025-00682-5","article-title":"Metabolomic biomarkers in vitreous humor: unveiling the molecular landscape of diabetic retinopathy progression","volume":"11","author":"Hiller","year":"2025","journal-title":"Int J Retina Vitreous"},{"key":"10.1016\/j.metabol.2026.156601_bb0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241365","article-title":"Metabolomics profiles associated with diabetic retinopathy in type 2 diabetes patients","volume":"15","author":"Yun","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.metabol.2026.156601_bb0510","article-title":"Multiplatform metabolomics reveals novel serum metabolite biomarkers in diabetic retinopathy subjects","volume":"7","author":"Xuan","year":"2020","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.metabol.2026.156601_bb0515","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ajo.2021.09.021","article-title":"Plasma arginine and citrulline are elevated in diabetic retinopathy","volume":"235","author":"Peters","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.metabol.2026.156601_bb0520","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.757088","article-title":"Plasma metabolomics reveals metabolic profiling for diabetic retinopathy and disease progression","volume":"12","author":"Sun","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.metabol.2026.156601_bb0525","article-title":"Serum untargeted metabolomics reveal potential biomarkers of progression of diabetic retinopathy in Asians","volume":"9","author":"Wang","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.metabol.2026.156601_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2023.130316","article-title":"A characteristic N-glycopeptide signature associated with diabetic cognitive impairment identified in a longitudinal cohort study","volume":"1867","author":"Miura","year":"2023","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.1016\/j.metabol.2026.156601_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0318916","article-title":"Cognitive decline in older adults with type 2 diabetes: unraveling site-specific glycoproteomic alterations","volume":"20","author":"Levin","year":"2025","journal-title":"PloS One"},{"key":"10.1016\/j.metabol.2026.156601_bb0540","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.2337\/db19-0145","article-title":"Impaired amino acid and TCA metabolism and cardiovascular autonomic neuropathy progression in type 1 diabetes","volume":"68","author":"Mathew","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2026.156601_bb0545","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/acn3.51639","article-title":"Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes","volume":"9","author":"Afshinnia","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.metabol.2026.156601_bb0550","doi-asserted-by":"crossref","first-page":"14688","DOI":"10.1038\/s41598-025-99606-4","article-title":"Metabolomic signatures of cognitive function in a type 2 Diabetes-Enriched cohort","volume":"15","author":"Powell","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2026.156601_bb0555","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2337\/db15-0863","article-title":"NETosis delays diabetic wound healing in mice and humans","volume":"65","author":"Fadini","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2026.156601_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2019.06.008","article-title":"Amino acids and wound healing in people with limb-threatening diabetic foot ulcers","volume":"33","author":"Hung","year":"2019","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.metabol.2026.156601_bb0565","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.2337\/db20-0188","article-title":"Integrated skin transcriptomics and serum multiplex assays reveal novel mechanisms of wound healing in diabetic foot ulcers","volume":"69","author":"Theocharidis","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2026.156601_bb0570","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.1111\/dom.70001","article-title":"Metabolomic risk predictors of diabetic foot complications: A longitudinal observational study in type 1 diabetes","volume":"27","author":"Andersen","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2026.156601_bb0575","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4591938","article-title":"Risk factors for cognitive impairment in patients with type 2 diabetes","volume":"2020","author":"Sun","year":"2020","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.metabol.2026.156601_bb0580","doi-asserted-by":"crossref","first-page":"8825","DOI":"10.1021\/acs.jmedchem.8b01005","article-title":"Validation of matrix metalloproteinase-9 (MMP-9) as a novel target for treatment of diabetic foot ulcers in humans and discovery of a potent and selective small-molecule MMP-9 inhibitor that accelerates healing","volume":"61","author":"Nguyen","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.metabol.2026.156601_bb0585","doi-asserted-by":"crossref","DOI":"10.1002\/prca.202300133","article-title":"Characterization of the metabolic proteome of serum from patients with diabetic distal symmetric polyneuropathy","volume":"18","author":"Zheng","year":"2024","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.metabol.2026.156601_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156467","article-title":"Metabolomic aging clock predicts risk of different cardiovascular diseases in the UK Biobank","volume":"176","author":"You","year":"2026","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156601_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156263","article-title":"Cross-sectional, interventional, and causal investigation of insulin sensitivity using plasma proteomics in diverse populations","volume":"169","author":"Kho","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156601_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114127","article-title":"From degenerative disease to malignant tumors: insight to the function of ApoE","volume":"158","author":"Miao","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.metabol.2026.156601_bb0605","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.1038\/s41467-025-62101-5","article-title":"Urinary Complement proteome strongly linked to diabetic kidney disease progression","volume":"16","author":"Md Dom","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2026.156601_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.01.014","article-title":"Natural compounds improve diabetic nephropathy by regulating the TLR4 signaling pathway","volume":"14","author":"Wu","year":"2024","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.metabol.2026.156601_bb0615","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-026-06695-5","article-title":"A diabetes-induced change of MDM2 SNP309T\u2192G contributes to aberrant retinal angiogenesis","author":"Ma","year":"2026","journal-title":"Diabetologia"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526001113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526001113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:56:14Z","timestamp":1793944574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049526001113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":123,"alternative-id":["S0026049526001113"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156601","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteomics and metabolomics biomarkers for predicting the onset and progression of diabetic complications: A systematic review and bioinformatics integration","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156601","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156601"}}